top of page

HEK293 hPPARγ-GAL4.0-luc Cell Line

Item
Cat#
Price

Stable Cell Line

SNB-NR-0004

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


hPPARγ (human Peroxisome Proliferator-Activated Receptor gamma) is a ligand-activated nuclear transcription factor belonging to the PPAR subtype of the nuclear receptor superfamily. It is primarily distributed in adipose tissue, macrophages, colon, retina, and certain immune cells. The main functions of hPPARγ include regulating adipocyte differentiation and lipid storage, enhancing insulin sensitivity, modulating inflammatory responses, and playing protective roles in glucose metabolism and atherosclerosis. It is also the target of thiazolidinediones, a class of antidiabetic drugs used clinically.


A CMV driven expression pcDNA3.1 vector consisting of Gal4-DNA binding domain and hPPARγ ligand binding domain and a pcDNA3.1 vector containing Gal4 responsive promoter firefly luciferase reporter gene were co-transfected and stably expressed in HEK293 cell line. The cell line is designed to detect the response to the stimulation of hPPARγ ligands. Promega One-Glo kit can be used to detect the signal.


Product Specifications

Target Type

Nuclear Receptor

Species

Human

HGNC Symbol

PPARG

Accession Number

NM_005037 (Hs)

Parental Line

HEK293

Lot#

See Vial

Storage

Liquid Nitrogen


Data

HEK293/hPPARγ-GAL4.0-luc Agonist Assay. HEK293/hPPARγ-GAL4.0-luc cells were treated with agonist. The assay was run based on Promega ONE-GLOTM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
HEK293/hPPARγ-GAL4.0-luc Agonist Assay. HEK293/hPPARγ-GAL4.0-luc cells were treated with agonist. The assay was run based on Promega ONE-GLOTM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
HEK293/hPPARγ-GAL4.0-luc Antagonist Assay. HEK293/hPPARγ-GAL4.0-luc cells were treated with antagonist. The assay was run based on Promega ONE-GLOTM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
HEK293/hPPARγ-GAL4.0-luc Antagonist Assay. HEK293/hPPARγ-GAL4.0-luc cells were treated with antagonist. The assay was run based on Promega ONE-GLOTM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.

Target Background


hPPARγ (human Peroxisome Proliferator-Activated Receptor gamma) is a ligand-activated nuclear transcription factor belonging to the PPAR subtype of the nuclear receptor superfamily. It is primarily distributed in adipose tissue, macrophages, colon, retina, and certain immune cells.


The main functions of hPPARγ include regulating adipocyte differentiation and lipid storage, enhancing insulin sensitivity, modulating inflammatory responses, and playing protective roles in glucose metabolism and atherosclerosis. It is also the target of thiazolidinediones, a class of antidiabetic drugs used clinically.


Product Documentation



Related Products

Screeningbio

For research use only. All rights reserved. Not for use in diagnostic procedures, human or veterinary treatment, food, cosmetics, or household applications. ScreeningBio provides laboratory research products and R&D services to qualified research organizations. We do not sell pharmaceuticals, dietary supplements, or products intended for human consumption.

6181 Cornerstone Ct, Suite 102, San Diego, CA 92121, USA

Quick Links

Connect

  • Facebook
  • Twitter
  • LinkedIn

CHINA: 上海格宁生物

info@screeningbio.com

4th Floor, Building 24, No.1188 Lianhang Road Minhang District, Shanghai, China

bottom of page